Pinacidil, an antihypertensive agent that opens potassium channels, lowers plasma aldosterone levels in hypertensive patients by an unknown mechanism. In the present study, pinacidil's direct effects on production of aldosterone were assessed using isolated cells from bovine adrenal glomerulosa. Pinacidil was found to inhibit aldosterone production, both basally and during stimulation with either potassium, angiotensin II (Ang II), or adrenocorticotropic hormone (/><0.001), with half maximal inhibition occurring at 10~5 M. As assessed by the exclusion of trypan blue from cells, pinacidil did not inhibit secretion through injurious effects on glomerulosa cells. Also, washing of cells previously exposed to pinacidil restored secretory responsiveness. Pinacidil did not alter cytosolic calcium (Ca 2+ ) concentrations when aequorin was used as a photoluminescent indicator of Ca 2+ levels, suggesting that pinacidil acted by a non-Ca 2+ -mediated mechanism. Consistent with direct inhibition of the late pathway in steroidogenesis was that pinacidil decreased conversion of pregnenolone and corticosterone to aldosterone. Pinacidil did not block binding of Ang II to its receptor, nor did it appear to affect adrenocorticotropic hormone-receptor binding, since stimulation by cyclic AMP, the postreceptor second messenger of adrenocorticotropic hormone, was also inhibited. In summary, pinacidil inhibited directly the adrenal's production of aldosterone. The mechanism whereby the inhibition occurred was unclear. (Hypertension 1991;18:529-534)
P
inacidil is an antihypertensive agent that acts by dilating resistance vasculature. 12 In clinical trials of pinacidil's antihypertensive properties, pinacidil treatment was associated with a lowering of plasma aldosterone levels and an increase in plasma renin activity, 3 levels of which reflect the concentration of angiotensin II (Ang II), a major stimulus of aldosterone secretion.
Pinacidil is a K + channel opener, 4 and in vascular smooth muscle pinacidil raises the electrical potential of myocytes by increasing K + efflux and the K + -mediated current across the cell membrane, 5 thereby reducing calcium (Ca 2+ ) influx through voltage sensitive Ca 2+ channels (VSCCs). Adrenal glomerulosa, the site of aldosterone synthesis, is highly responsive to a change in the level of membrane potential. For example, a small increase in extracellular K + concentration, which reduces membrane potential only slightly, increases Ca 2+ influx and stimulates aldosterone secretion. 6 ' 7 Pinacidil might therefore lower aldosterone secretion by increasing membrane potential and reducing Ca 2+ influx through voltage sensitive Ca 2+ channels. In the present study, pinacidil's effects on aldosterone production were examined in vitro using bovine adrenal cells. We report here on the effect of pinacidil to inhibit aldosterone production under basal conditions as well as during stimulation with either Ang II, K + , or adrenocorticotropic hormone (ACTH). In addition, we describe results of experiments that attempted to examine the mechanism for inhibition, including studies of pinacidil's effects on cytosolic Ca 2+ levels.
saline. A Stadie-Riggs microtome was used to remove the outer 0.5 mm of cortex that contained the zona glomenilosa. The inner 0.5 mm of subcapsular cortex was used to harvest zona fasciculata cells. Cortical tissues were digested in 2 mg/ml collagenase and 25 p,g/ml type II DNase at 37°C for 1 hour. Isolated cells were washed three times in Krebs' bicarbonate buffer. The effect of pinacidil on aldosterone production was examined under basal conditions and during stimulation with either K + (12 mM), 10" 7 M Ang II, 10~7 M ACTH, or 10" 3 M 8-bromo-cAMP. Pinacidil, 2.63 mg (molecular weight 263), was dissolved in 200 /xl methanol and then taken up in 10 ml Krebs' bicarbonate buffer. The final concentration of methanol was adjusted to 0.2% (vol/vol) for all incubation media, although this concentration of methanol had no effect on aldosterone secretion. The final concentrations of pinacidil examined were 10" 7 to 10~4 M. Cells were preincubated for 30 minutes at 5.0 mM K + and then transferred to fresh medium where they were incubated with pinacidil for 15 minutes before the addition of the stimulus. The final incubation, with or without the addition of stimulus, was carried out for 60 minutes at 37°C in a 95% 0^5 % CO 2 mixture. Similar experiments were performed after the addition of either pregnenolone (500 ng/ml) or corticosterone (250 ng/ml) as precursors to aldosterone. The incubation medium also contained 10~4 M cycloheximide, and no stimulus was added. Fasciculata cells were used to assess the effects of 10~6 and 10" 5 M pinacidil on cortisol production. The reversibility of the effect of pinacidil on aldosterone secretion was examined by incubating glomenilosa cells with 10" 5 M pinacidil for 60 minutes and then removing the pinacidil by centrifugation and exposing the glomenilosa cells to 10~7 M Ang II.
AJdosterone was quantified by radioimmunoassay using antisera from Diagnostic Products Corp., Los Angeles, Calif., and cortisol was assayed using the Diagnostic Products Coat-a-Count radioimmunoassay kit.
Angiotensin II Binding Experiments
The effect of pinacidil on Ang II binding to glomenilosa cells was studied in Ca -free Krebs' bicarbonate buffer with 0.1 mM EGTA to minimize Ang II degradation. The effect of 10" 6 to 10" 4 M pinacidil on displacement of labeled Ang II by 10" 7 to 10" 5 M Ang II was tested. Incubations were carried out for 10 minutes, and then cells were centrifuged. The displacement of labeled Ang II bound to glomenilosa cells was used as an indicator of Ang II binding.
Aequorin Experiments to Assess Changes in Cytosolic Ca

2+
Bovine adrenal cells were prepared and then loaded with the Ca 2+ -stimulated luminescent probe, aequorin. 8 Cells were suspended in agarose gel and then perfused at a rate of 1.0 ml/min at 37°C. 9 The amount of aequorin light emitted at the end of the 
Statistical Analysis
The effects of a range of pinacidil concentrations on aldosterone secretion were examined by analysis of variance. Where appropriate the nonpaired t test was used. Results are presented as the mean±SEM.
Results
Pinacidil caused a dose-dependent inhibition of aldosterone secretion under basal conditions (/?<0.001) ( Figure 1 ) and during Ang II-, K + -, or ACTH-stimulated aldosterone secretion (p<0.001 for each stimulus) ( Figure 2 ). Regardless of the stimulus, secretion rates were reduced by more than half with 10~5 M pinacidil. Pinacidil at concentration of 10" 6 and 10" 5 M did not affect basal production of cortisol but did inhibit 10~7 M ACTH-stimulated production. In the presence of ACTH but no pinacidil, cortisol production was 159±3.5 (SEM) ng/min/ 10 6 cells; after the addition of 10" 6 and 10" 5 M pinacidil, cortisol production was 144.0±2.8 (p=0.000 when compared with ACTH alone) and 125.6±6.13 ng/min/10 6 cells (/>=0.004), respectively.
In Table 1 are shown effects of pinacidil on aldosterone production after the addition of precursor steroids. Conversion of pregnenolone to aldosterone was inhibited by 10" 5 M pinacidil, as was conversion of corticosterone to aldosterone, indicating that inhibition by pinacidil occurred at a late step in aldosterone biosynthesis.
No toxic effect of pinacidil was observed as assessed by trypan blue exclusion (more than 90% of glomenilosa cells excluded trypan blue). The effect of a 60-minute exposure to pinacidil on the subsequent stimulatory response to Ang II is shown in Figure 3 . A 60 -minute exposure of adrenal cells to 1(T 5 M pinacidil decreased basal secretion of aldosterone (p<0.001). Then, after replacing the medium containing pinacidil with medium containing 10~7 M Ang II, there was a fourfold increase in aldosterone secretion (p< 0.001). Thus, inhibition of secretion by pinacidil was reversible and did not result from a toxic effect of pinacidil on cells. The secretory response to 10" 6 M Ang II was in fact significantly greater when cells had been first incubated with pinacidil (p<0.001).
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In Ang II binding studies, pinacidil concentrations as high as 10~* M were without effects on binding of Ang II to its receptor (Figure 4) . Pinacidil also inhibited 8-bromo-cAMP-stimulated secretion (Figure 5) , and thus ACTH-mediated stimulation, which uses cAMP as a second messenger, 10 was inhibited beyond the point of interaction with the ACTH receptor.
Cytosolic Ca 2+ levels depicted as the log Lt/Lmai of the luminescence generated by glomerulosa cells preloaded with aequorin are shown in Figure 6 . 
Discussion
In the present study, pinacidil inhibited aldosterone production in vitro under basal conditions as well as during stimulation with either Ang II, K + , or ACTH. Such an effect on the adrenal could explain the lower plasma aldosterone levels in patients receiving pinacidil as treatment for hypertension. 3 How pinacidil inhibited aldosterone production was, however, unclear.
Both First, using the photoluminescent probe aequorin, we could show no effect of pinacidil on cytosolic Ca 2+ with either K + or Ang II as the stimulus. Considering the strong inhibition of aldosterone secretion that occurred with this concentration of pinacidil, we would have anticipated an observable decline in cytosolic Ca 2+ . Second, pinacidil inhibited the conversion of pregnenolone as well as corticosterone to aldosterone, inhibition at a late step in biosynthesis, consistent with inhibition of 18-hydroxylation. The late synthetic pathway lies within mitochondria, 16 which are presumably isolated from signaling events at the outer cell membrane. Such observations indicate a more direct inhibition of enzymatic activity as opposed to an effect of pinacidil to hyperpolarize the cell membrane. Third, stimulation by ACTH is coupled principally to cAMP, 10 and not to increases in cytosolic Ca 
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been too small or too restricted to critical areas near the cell membrane 17 for us to observe changes with the techniques used. Also, whether events at the outer membrane can affect the mitochondrial late pathway is not clear since Ang II has been shown to affect stimulation of the late pathway. 16 - 18 In addition, AUl'H has been shown to reduce K + efflux from glomerulosa cells, 19 and conceivably this action by AUl'H was inhibited by pinacidil.
Additional experiments were carried out to examine the influence of pinacidil on Ang II receptor binding. Since Ang II appears to reduce K + efflux from glomerulosa cells, 20 we considered the possibility that pinacidil increased K + efflux by blocking Ang II receptor binding. However, no effect on Ang II binding by pinacidil was observed. Additional studies ruled out an effect of pinacidil to antagonize binding to the ACTH receptor. The administration of 8-bromo-cAMP, which bypasses receptor binding, was also inhibited by pinacidil.
Pinacidil produced a modest decrease in ACTHstimulated cortisol production by fasciculata cells -a decline of 10% and 20% with concentrations of 10" 6 and 10" 5 M pinacidil, respectively. There was no effect of pinacidil on the basal production rate of cortisol. The relevance of these observations to cortisol production during treatment with pinacidil is not known. There have been no published accounts of measurements of cortisol secretion in patients treated with pinacidil.
Pinacidil was not injurious to cells, as evidenced by trypan blue exclusion analysis, nor did pinacidil result in a permanent loss of secretory function. When pinacidil was subsequently removed from the incubation media, the stimulatory response to Ang II was actually augmented, as if the pinacidil had preserved the integrity of the glomerulosa's secretory capacity.
Concentrations of pinacidil that are achieved in vivo during treatment of patients with hypertension reach values of about 0.80 JAM (200 ng/ml), 2 -21 concentrations significantly lower than the 10 /iM used to inhibit aldosterone secretion in the present study. To lower contractility of vascular smooth muscle, the in vitro physiological equivalent of pinacidil's antihypertensive effect, approximately 10 yM pinacidil was required 3 or the same amount that inhibited aldosterone production. The observations made using the bovine adrenal, bearing in mind the limitations on adrenal responsiveness imposed by conditions associated with in vitro experiments, are thus likely to have pharmacological relevance when therapeutic doses of pinacidil are used.
Other antihypertensive agents that are thought to affect vasculature by opening K + channels include minoxidil 22 and cromakalim. 23 The use of both antihypertensive drugs has been associated with decreases in plasma aldosterone concentrations and increases in plasma renin activity, 24 -25 and thus both minoxidil and cromakalim may also impair the adrenal's secretion of aldosterone. Minoxidil, in addition, may lower aldosterone levels by increasing the aldosterone metabolic clearance rate. 26 The antihypertensive benefit derived from a lowering of aldosterone levels is not known. The experience with K + channel openers in treating patients with primary aldosteronism has not, to our knowledge, been reported.
In summary, pinacidil inhibited basal as well as stimulated aldosterone secretion in vitro. The mechanism for the inhibition was unclear. This effect of pinacidil may at least partially explain the lowering of plasma aldosterone concentrations in hypertensive patients treated with pinacidil. The present findings suggest that pinacidil may prove particularly beneficial to hypertensive patients in whom high aldosterone levels contribute to the increase in blood pressure. effects of potassium, 5-hydraxytryptamine, adrenocorticotropin and angiotensin II on the concentrations of adenosine 3':5'-cyclic monophosphate in suspensions of dispersed rat adrenal zona glomerulosa and zona fasciculata cells. 
